Credit Suisse’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$8.37M Buy
352,756
+7,204
+2% +$160K 0.01% 1006
2023
Q4
$8.29M Sell
345,552
-2,906
-0.8% -$63.2K 0.01% 1026
2023
Q3
$7.61M Sell
348,458
-54,471
-14% -$1.14M 0.01% 1033
2023
Q2
$7.7M Sell
402,929
-88,168
-18% -$1.7M 0.01% 1058
2023
Q1
$9.53M Buy
491,097
+8,769
+2% +$153K 0.01% 958
2022
Q4
$7.74M Buy
482,328
+65,202
+16% +$1.06M 0.01% 1047
2022
Q3
$6.54M Buy
417,126
+33,465
+9% +$647K 0.01% 1114
2022
Q2
$7.99M Buy
383,661
+32,054
+9% +$661K 0.01% 1029
2022
Q1
$7.97M Buy
351,607
+18,738
+6% +$366K 0.01% 1155
2021
Q4
$6.08M Sell
332,869
-59,499
-15% -$1.14M ﹤0.01% 1869
2021
Q3
$8.29M Sell
392,368
-34,307
-8% -$637K ﹤0.01% 1670
2021
Q2
$7.78M Sell
426,675
-46,493
-10% -$1.08M ﹤0.01% 1732
2021
Q1
$10.7M Sell
473,168
-140,081
-23% -$3.16M 0.01% 1547
2020
Q4
$12.3M Buy
613,249
+177,656
+41% +$3.72M 0.01% 1453
2020
Q3
$10.7M Sell
435,593
-8,679
-2% -$203K 0.01% 1350
2020
Q2
$10.5M Buy
444,272
+47,582
+12% +$1.1M 0.01% 1264
2020
Q1
$6.83M Sell
396,690
-4,460
-1% -$81.6K 0.01% 1371
2019
Q4
$7.07M Buy
401,150
+94,122
+31% +$1.6M 0.01% 1639
2019
Q3
$5.43M Sell
307,028
-120,526
-28% -$2.44M ﹤0.01% 1702
2019
Q2
$9.14M Buy
427,554
+89,033
+26% +$1.87M 0.01% 1367
2019
Q1
$8.06M Buy
338,521
+17,177
+5% +$392K 0.01% 1374
2018
Q4
$6.32M Buy
321,344
+7,785
+2% +$139K 0.01% 1425
2018
Q3
$5.55M Sell
313,559
-161,789
-34% -$3.15M 0.01% 1628
2018
Q2
$10.2M Sell
475,348
-511,732
-52% -$10.6M 0.01% 1229
2018
Q1
$21.9M Buy
987,080
+211,246
+27% +$5.84M 0.02% 804
2017
Q4
$23.6M Sell
775,834
-3,004
-0.4% -$79.9K 0.02% 799
2017
Q3
$18.9M Sell
778,838
-129,397
-14% -$3.44M 0.02% 870
2017
Q2
$22.4M Buy
908,235
+140,125
+18% +$2.97M 0.02% 754
2017
Q1
$16.6M Buy
768,110
+128,398
+20% +$2.61M 0.02% 931
2016
Q4
$9.54M Buy
639,712
+290,580
+83% +$4.19M 0.01% 1232
2016
Q3
$4.47M Sell
349,132
-58,600
-14% -$634K ﹤0.01% 1752
2016
Q2
$3.19M Sell
407,732
-741,931
-65% -$4.28M ﹤0.01% 1986
2016
Q1
$4.6M Buy
1,149,663
+1,033,850
+893% +$4.38M 0.01% 1602
2015
Q4
$653K Sell
115,813
-57,944
-33% -$324K ﹤0.01% 3174
2015
Q3
$975K Sell
173,757
-295,461
-63% -$1.61M ﹤0.01% 2843
2015
Q2
$1.76M Buy
469,218
+64,003
+16% +$208K ﹤0.01% 2653
2015
Q1
$1.04M Sell
405,215
-37,162
-8% -$86.2K ﹤0.01% 2937
2014
Q4
$638K Buy
442,377
+226,114
+105% +$352K ﹤0.01% 3528
2014
Q3
$331K Sell
216,263
-56,606
-21% -$182K ﹤0.01% 3883
2014
Q2
$926K Buy
272,869
+16,057
+6% +$55.4K ﹤0.01% 3364
2014
Q1
$909K Sell
256,812
-57,030
-18% -$388K ﹤0.01% 3211
2013
Q4
$1.92M Buy
313,842
+31,158
+11% +$172K ﹤0.01% 2679
2013
Q3
$1.65M Buy
282,684
+71,780
+34% +$371K ﹤0.01% 2563
2013
Q2
$958K Buy
+210,904
New +$1,000K ﹤0.01% 2829

Other funds holding EXEL

Credit Suisse's EXEL Position: Q1 2024 in Review

Credit Suisse increased its Exelixis (EXEL) stake by 2.1% in Q1 2024, buying an estimated $160K and bringing the position to 352,756 shares worth $8.37M. The position accounts for 0.01% of the portfolio, ranked #1006.

Credit Suisse first reported a position in EXEL in Q2 2013 and has held it in 44 quarters since. The position peaked at $23.6M in Q4 2017. 423 funds tracked by Wall St. Rank hold EXEL as of Q1 2024.

  • Credit Suisse held 352,756 shares of Exelixis worth $8.37M as of Q1 2024.
  • Credit Suisse bought 7,204 Exelixis shares in Q1 2024, an estimated $160K.
  • Exelixis made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1006 holding.
  • Credit Suisse first reported a position in Exelixis in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Exelixis position peaked at $23.6M in Q4 2017.
  • 423 funds tracked by Wall St. Rank held Exelixis as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.